$1.06
-0.03[-2.75%]
At close: May 16
Lineage Cell Therapeutics
(AMEX:LCTX)Lineage Cell Therapeutics Stock (AMEX:LCTX), Earnings Estimates, EPS, and Revenue
Lineage Cell Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 9
EPS
$-0.040
Quarterly Revenue
$1.4M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$8M
Analyze the earnings history of Lineage Cell Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LCTX | Lineage Cell Therapeutics | -$0.03 | — | — | — | $3.23M | — | — | — | 08/08/2024 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.03 | -$0.04 | -$0.04 | 0.00% | $2.39M | $1.36M | $1.44M | 6.18% | 05/09/2024 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.03 | -$0.04 | -$0.03 | 25.00% | $1.90M | $1.31M | $2.10M | 60.31% | 03/07/2024 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.04 | -$0.04 | -$0.04 | 0.00% | $3.00M | $2.59M | $1.25M | -51.89% | 11/09/2023 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.04 | -$0.04 | -$0.03 | 25.00% | $4.55M | $2.20M | $3.23M | 46.59% | 08/10/2023 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.04 | -$0.04 | -$0.03 | 25.00% | $5.24M | $2.01M | $2.39M | 18.71% | 05/11/2023 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.17 | -$0.04 | -$0.03 | 25.00% | $1.20M | $2.57M | $1.90M | -26.07% | 03/09/2023 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.05 | -$0.03 | -$0.04 | -33.33% | $2.27M | $3.90M | $3.00M | -23.13% | 11/10/2022 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.03 | -$0.04 | -$0.04 | 0.00% | $512.00K | $3.68M | $4.55M | 23.72% | 08/11/2022 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.01 | -$0.03 | -$0.04 | -33.33% | $391.00K | $7.32M | $5.24M | -28.46% | 05/12/2022 | Get Alert |
| LCTX | Lineage Cell Therapeutics | $0.01 | -$0.05 | -$0.17 | -240.00% | $355.00K | $840.00K | $1.20M | 42.86% | 03/10/2022 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.05 | -$0.05 | -$0.05 | 0.00% | $571.00K | — | $2.27M | — | 11/10/2021 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.04 | -$0.04 | -$0.03 | 25.00% | $386.00K | $480.00K | $512.00K | 6.67% | 08/12/2021 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.06 | -$0.04 | -$0.01 | 75.00% | $514.00K | $790.00K | $391.00K | -50.51% | 05/13/2021 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.03 | -$0.05 | $0.01 | 120.00% | $1.24M | $920.00K | $355.00K | -61.41% | 03/11/2021 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.11 | -$0.04 | -$0.05 | -25.00% | $567.00K | $430.00K | $571.00K | 32.79% | 11/04/2020 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.20 | -$0.04 | -$0.04 | 0.00% | $779.00K | $560.00K | $386.00K | -31.07% | 08/06/2020 | Get Alert |
| LCTX | Lineage Cell Therapeutics | $0.30 | -$0.05 | -$0.06 | -20.00% | $928.00K | $710.00K | $514.00K | -27.61% | 05/07/2020 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.36 | -$0.05 | -$0.03 | 40.00% | $758.00K | $1.03M | $1.24M | 20.49% | 03/12/2020 | Get Alert |
| LCTX | Lineage Cell Therapeutics | $0.53 | -$0.05 | -$0.11 | -120.00% | $982.00K | $810.00K | $567.00K | -30.00% | 11/12/2019 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.03 | -$0.05 | -$0.20 | -300.00% | $2.55M | $990.00K | $779.00K | -21.31% | 08/08/2019 | Get Alert |
FAQ
When is Lineage Cell Therapeutics (AMEX:LCTX) reporting earnings?
Lineage Cell Therapeutics (LCTX) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for Lineage Cell Therapeutics (AMEX:LCTX)?
The Actual EPS was $-0.04, which hit the estimate of $-0.04.
What were Lineage Cell Therapeutics’s (AMEX:LCTX) revenues?
The Actual Revenue was $1.4M, which beat the estimate of $1.4M.
Browse earnings estimates, EPS, and revenue on all stocks.